2019
DOI: 10.1016/j.biopha.2018.10.016
|View full text |Cite
|
Sign up to set email alerts
|

Teneligliptin protects against hypoxia/reoxygenation-induced endothelial cell injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…It is also shown to prevent atherosclerosis through the suppression of monocyte chemoattractant protein-1 expression, and pro-inflammatory cytokine production. In addition, TEN is also known to enhance glutathione antioxidant production within the cells [ 16 ]. Indeed, TEN is reported to possess more ·OH scavenging ability compared to the naturally occurring antioxidant glutathione and to possess direct ·OH scavenging ability [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…It is also shown to prevent atherosclerosis through the suppression of monocyte chemoattractant protein-1 expression, and pro-inflammatory cytokine production. In addition, TEN is also known to enhance glutathione antioxidant production within the cells [ 16 ]. Indeed, TEN is reported to possess more ·OH scavenging ability compared to the naturally occurring antioxidant glutathione and to possess direct ·OH scavenging ability [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…In disease conditions, LDH activity is elevated and contributes towards the progression of DR from stage 1 to stage 4 [58]. Experimentally, an inhibitor of LDH release, i.e., teneligliptin, protected the retinal endothelial cell from injury against the hypoxia/reoxygenation events [59]. In the present study, the results revealed that AST has the potential to reduce the LDH level and raise the catalase level in retinal tissue against the STZ toxicity on mice retina and delay the progression of DR.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study found that teneligliptin could rescue endothelial cell viability in rat cardiac microvascular endothelial cells exposed to hypoxia/reoxygenation injury. 26 While there is considerable evidence that DPP-4 inhibition can improve endothelial cell viability and function after ischemia/reperfusion, the role of teneligliptin in protecting brain endothelial cells from OGD/R-induced injury is not clear. 27 Our experiments demonstrate that teneligliptin significantly rescued this OGD/R-induced decreased cell viability in a dose-dependent manner, and remarkably, the higher dose almost completely restored cell viability.…”
Section: Discussionmentioning
confidence: 99%